Bezalel Innovations

Bezalel Innovations

Palo Cedro, CA
Express Interest
Bezalel Innovations is a Christian company that has a patent pending for a novel surgical tourniquet which will revolutionize the surgical tourniquet industry. Bezalel Innovations was founded on the core values that God is good, anything is possible with God, there are no hopeless circumstances and what we believe about what we are doing is more important than what we are doing. This company aims to raise up big people, not solely a big company. The culture of this company is to empower each other and be a light of encouragement to the world. The company is named after Bezalel who God appointed to build the tabernacle. God imparted His spirit of wisdom to innovate and build in Bezlalel. Bezalel Innovations Automated Compressive Tourniquet System (ACTS) decreases health care facility expenses. There is no other tourniquet on the market is like this. Product development is expected to take 8 months. During this time brand distillation, social media presence, website creation, 3-D imaging/animation, sales team tools will be developed. Additionally the sales team will develop a CRM and begin business to business relationship building. $2.5M is needed to fund product development, manufacturing and business operations for 3 years. With a potential and anticipated 24 month EBIT of $35M, equity of 10% and a multiplier of 7.0, the IRR is expected to be 238% valuing a 2 year target return of $27M. www.bezalelinnovations.com plagaay@bezalelinnovations.com

Bezalel Innovations is a Christian company that has a patent pending for a novel surgical tourniquet which will revolutionize the surgical tourniquet industry. Bezalel Innovations was founded on the core values that God is good, anything is possible with God, there are no hopeless circumstances and what we believe about what we are doing is more important than what we are doing. This company aims to raise up big people, not solely a big company. The culture of this company is to empower each other and be a light of encouragement to the world. The company is named after Bezalel who God appointed to build the tabernacle. God imparted His spirit of wisdom to innovate and build in Bezlalel. Bezalel Innovations Automated Compressive Tourniquet System (ACTS) decreases health care facility expenses. There is no other tourniquet on the market is like this. Product development is expected to take 8 months. During this time brand distillation, social media presence, website creation, 3-D imaging/animation, sales team tools will be developed. Additionally the sales team will develop a CRM and begin business to business relationship building. $2.5M is needed to fund product development, manufacturing and business operations for 3 years. With a potential and anticipated 24 month EBIT of $35M, equity of 10% and a multiplier of 7.0, the IRR is expected to be 238% valuing a 2 year target return of $27M. www.bezalelinnovations.com plagaay@bezalelinnovations.com

Company Overview

Bezalel Innovations is a Christian company that has a patent pending for a novel surgical tourniquet which will revolutionize the surgical tourniquet industry.

Bezalel Innovations was founded on the core values that God is good, anything is possible with God, there are no hopeless circumstances and what we believe about what we are doing is more important than what we are doing. This company aims to raise up big people, not solely a big company. The culture of this company is to empower each other and be a light of encouragement to the world. The company is named after Bezalel who God appointed to build the tabernacle. God imparted His spirit of wisdom to innovate and build in Bezlalel.

Bezalel Innovations Automated Compressive Tourniquet System (ACTS) decreases health care facility expenses. There is no other tourniquet on the market is like this.

Product development is expected to take 8 months. During this time brand distillation, social media presence, website creation, 3-D imaging/animation, sales team tools will be developed. Additionally the sales team will develop a CRM and begin business to business relationship building.

$2.5M is needed to fund product development, manufacturing and business operations for 3 years. With a potential and anticipated 24 month EBIT of $35M, equity of 10% and a multiplier of 7.0, the IRR is expected to be 238% valuing a 2 year target return of $27M.

www.bezalelinnovations.com plagaay@bezalelinnovations.com

Products & Services

Automated Compressive Tourniquet System (ACTS)

Bezalel Innovations Automated Compressive Tourniquet System (ACTS) decreases health care facility expenses. This tourniquet is revolutionary, no other tourniquet on the market is like this.

Team

P

Pieter L

PRESIDENT

Stay in the Loop

Get updates from Bezalel Innovations

Get exclusive updates from Bezalel Innovations

Be the first to know about company milestones, news, and opportunities.

Get Company Updates

🔒 No spam. Just real progress.

Company Stats

Key metrics about Bezalel Innovations

Industry MEDICAL DEVICES & EQUIPMENT

Fuel Level

Engagement metrics for Bezalel Innovations

0
Fuel Points

Fuel represents engagement and interest in this company from the Crowdigy community.

Are you the owner of Bezalel Innovations?

Claim your company profile to respond to reviews, update your information, and connect with investors.

Claim This Company

Disclosures

crowdigy.com is a website owned by Crowdigy LLC. Crowdigy LLC. operates sections of crowdigy.com where certain Regulation Crowdfunding, Regulation D and Regulation A+ offerings are available. Crowdigy LLC. is not regulated in any capacity, is not registered as either a broker-dealer or funding portal, and is not a member of FINRA or any other self-regulatory organization.

In making an investment decision, investors must rely on their own examination of the issuer and the terms of the offering, including the merits and the risks involved. Investing in companies is a highly risky activity, which may include a risk or loss capital. Crowdigy LLC is not making any guarantees. If investors lose all or part of their investments, the investors will not have a right to recover from Crowdigy LLC except only to the extent Crowdigy LLC is determined to be liable under current securities laws.

Information displayed by crowdigy.com that is not controlled or accessed by registered investors or companies features information publicly available through open internet platforms or publicly released information or data sources.

Anyone with a financial stake in a company in a fundraising capacity, such as a promoter, employee, or founder, must disclose their relationship when communicating with other investors. Investors should read our educational materials on startup investing. Educational materials are continually updated at https://crowdigy.com/investors.

By using crowdigy.com, you accept our Terms and Conditions & Privacy Policy. If investing, you accept our Investor Agreement. You may also view our Privacy Notice.

This is an electronic platform where business owners can be featured to raise money from investors in return for securities or other arrangements, and where investors can browse opportunities to invest. Opportunities or securities presented on this site have not been registered, recommended or approved by any federal or state securities commission, regulatory authority or Crowdigy LLC.

All the information on this site is provided by the issuers or publicly available information and any investments or investment details are facilitated by their funding portal.

All representations of information is not validated or certified by Crowdigy LLC and is the responsibility of the information providers or respective companies that control their own profiles or cards. By using Crowdigy you agree and understand Crowdigy is NOT a licensed broker-dealer and does not provide any investment advice or recommendation and does not provide any legal or tax advice with respect to any securities or offers. Any features, placements or promotions of opportunities on Crowdigy should not be construed as an endorsement or recommendation.

We use cookies on this site to enhance your user experience and analyze site traffic. By clicking "Accept", you consent to our use of cookies. Learn more